Global Brachytherapy Devices Market – Snapshot

The global brachytherapy devices market is driven by increase in incidence of cancer, high prevalence of cervical & lung cancer in developing regions, developed health care infrastructure, rise in demand for brachytherapy treatment, supportive government initiatives, and high acceptance of minimal invasive surgeries. However, higher reimbursement rates of other advanced radiation therapies, such as, IMRT and proton therapy and increase in demand for robotic prostatectomies are restraining the global brachytherapy devices market.

Obtain Report Details @

https://www.transparencymarketresearch.com/brachytherapy-devices-market-2018-2026.html

The global brachytherapy devices market has been segmented based on product type, dose rate, indication, end-user, and region. On the basis of product type, the global market has been classified into brachytherapy afterloaders, brachytherapy applicators, and others. The brachytherapy applicators segment has been bifurcated into intracavitary applicators, interstitial applicators, and others. Based on dose rate, the global brachytherapy devices market has been classified into high dose rate brachytherapy, low dose rate brachytherapy, pulse dose rate brachytherapy, and others. In terms of indication, the global brachytherapy devices market has been categorized into prostate cancer, breast cancer, cervical cancer, skin cancer, and others. By end-user, the global market has been divided into hospitals, cancer treatment centers, and others. The global brachytherapy devices market has been studied across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, in terms of region.

Request for Sample Copy of Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=52032

The brachytherapy applicators segment is estimated to expand at a CAGR of 8.4% and account for the dominant share of the  brachytherapy devices market during the forecast period. This therapy plays a pivotal role in cancer care treatment as they are more efficient and are used for patient navigation through cancer care continuum. Rise in investment in research & development on cancer also paves the way for the increasing demand for the therapy. Cervical cancer, being the fourth common type of cancer in women, affects 500,000 women every year globally. It is the largest growing market for brachytherapy, followed by prostate cancer, breast cancer, skin cancer, and others. Hospitals are the major customers of brachytherapy products as they have better reimbursement plans and advanced technology systems, followed by cancer treatment centers, and others.

Request Report Brochure @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=52032

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: www.transparencymarketresearch.com